A student ask the pharmacology instructor to describe the function of cholinergic agonist. What would be the instructor's reply?
It decreases the activity of norepinephrine receptor sites
It increases the activity of acetylcholine receptor site
It decreases the activity of GABA receptor sites
It increases the activity of dopamine receptor sites
The Correct Answer is B
A) It decreases the activity of norepinephrine receptor sites: Cholinergic agonists specifically act on acetylcholine receptors, not norepinephrine receptors. Norepinephrine is associated with the sympathetic nervous system and its receptors (alpha and beta), whereas cholinergic agonists affect the parasympathetic system through acetylcholine receptors.
B) It increases the activity of acetylcholine receptor sites: This is the correct answer. Cholinergic agonists work by stimulating acetylcholine receptors (both muscarinic and nicotinic), thereby enhancing the action of acetylcholine. This can lead to various effects such as decreased heart rate, increased digestion, and muscle contraction, as part of the parasympathetic nervous system response.
C) It decreases the activity of GABA receptor sites: GABA (gamma-aminobutyric acid) is an inhibitory neurotransmitter that acts on GABA receptors, not acetylcholine receptors. Cholinergic agonists have no direct effect on GABA receptor activity.
D) It increases the activity of dopamine receptor sites: Dopamine is a neurotransmitter primarily involved in the reward system, motor control, and mood regulation. Cholinergic agonists do not directly affect dopamine receptors. Instead, they target acetylcholine receptors, which are part of the parasympathetic nervous system.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A) Norepinephrine: Norepinephrine is a neurotransmitter primarily involved in the sympathetic nervous system. It is not involved in terminating the stimulation caused by acetylcholine. Norepinephrine acts on adrenergic receptors, whereas acetylcholine primarily acts on cholinergic receptors.
B) Decarboxylase: Decarboxylase is an enzyme that plays a role in the synthesis of certain neurotransmitters, including dopamine, but it does not have a role in terminating the action of acetylcholine at the effector cell. It is unrelated to the termination of acetylcholine signaling.
C) Catecholamine: Catecholamines (such as dopamine, norepinephrine, and epinephrine) are a group of neurotransmitters involved in the sympathetic nervous system. While they play a role in synaptic transmission, they are not responsible for breaking down acetylcholine or terminating its effects. Their primary function is in adrenergic signaling.
D) Acetylcholinesterase: Acetylcholinesterase is the correct enzyme. It is responsible for breaking down acetylcholine (ACh) in the synaptic cleft after it has stimulated the effector cell. By hydrolyzing acetylcholine into acetate and choline, acetylcholinesterase effectively terminates the signal and allows the effector cell's membrane to repolarize. This action prevents continuous stimulation and ensures proper function of the cholinergic system.
Correct Answer is A
Explanation
A) Celecoxib (Celebrex):
Celecoxib is a selective COX-2 inhibitor that targets the cyclooxygenase-2 enzyme, which is primarily responsible for inflammation, pain, and fever. COX-2 inhibitors tend to cause less gastrointestinal irritation compared to nonselective NSAIDs like aspirin, which block both COX-1 and COX-2 enzymes. Because aspirin is causing gastrointestinal upset, switching to Celecoxib, which is less likely to irritate the stomach lining, may be an appropriate option to prevent myocardial infarction while minimizing gastrointestinal discomfort.
B) Enteric-coated aspirin:
Enteric-coated aspirin is designed to dissolve in the small intestine rather than the stomach, which may reduce some gastrointestinal irritation. However, it does not eliminate the risk entirely, and it still functions as a COX-1 inhibitor. If the patient is already experiencing gastrointestinal upset, simply switching to enteric-coated aspirin may not be sufficient to alleviate the discomfort, and other options should be considered.
C) Nabumetone (Relafen):
Nabumetone is a nonsteroidal anti-inflammatory drug (NSAID) with some COX-2 selectivity. While it may cause less gastrointestinal upset than non-selective NSAIDs like aspirin, it is still an NSAID and carries a risk of gastrointestinal side effects, especially with prolonged use.
D) A COX-2 inhibitor:
While COX-2 inhibitors, including Celecoxib, are typically effective in reducing inflammation and pain with fewer gastrointestinal side effects than traditional NSAIDs, the term "a COX-2 inhibitor" could refer to various drugs, and Celecoxib (Celebrex) is the most commonly used.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.